RIPK3 and cancer: Another study showed that the activation of RIPK3 results in a reliable derepression of tripartite motif-containing 28 in cancer cells, thereby inducing increased production of immunostimulatory cytokines in the tumor microenvironment (TME), thus promoting potent cytotoxic antitumor immunity (10).